All contributors
Onconephrology contributor
Gupta, Shruti
Primarily Anticancer drug nephrotoxicity#17 of 46 recognizedHonor roll
- #3 in Anticancer drug nephrotoxicity
- #5 in Checkpoint-inhibitor kidney injury
36
Clinical papers
1,369
Citations (iCite)
16 / 2
First / senior author
2020–2026
Active years
Output over time
Clinical corpus papers per year — peak 7 in 2021.
- 2020: 3 papers
- 2021: 7 papers
- 2022: 5 papers
- 2023: 5 papers
- 2024: 5 papers
- 2025: 6 papers
- 2026: 5 papers
20202026
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Anticancer drug nephrotoxicity24
Checkpoint-inhibitor kidney injury12
Onco-nephrology (general)9
Cellular therapy renal effects5
Myeloma cast nephropathy3
Anti-VEGF / TKI renal effects1
Frequent co-authors
Other recognized contributors who most often share corpus papers with Gupta (shared-paper count).
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,541-article corpus (regenerated 2026-10-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.